Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Canadian Cancer Trials Group
NiKang Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
University of Michigan Rogel Cancer Center
UNC Lineberger Comprehensive Cancer Center